The recall does not include Methylin
oral solution (5 mg/5 mL and 10 mg/5 mL).
Several long-acting forms of methylphenidate (Concerta, Metadate CD, Methylin
ER, and Ritalin SR) are now on the market.
Methylphenidate * Methylin
, Ritalin Risperidone * Risperdal
Breckenridge also introduced methylphenidate solution, the generic version of Methylin
, which was filed with a Paragraph IV certification under the Hatch-Waxman Act.
The ruling will require the following 15 products to be dispensed with new patient medication guides: Adderall tablets, Adderall XR extended-release capsules, Concerta extended-release tablets, Daytrana transdermal system, Desoxyn tablets, Dexedrine Spansule capsules and tablets, Focalin tablets, Focalin XR extended-release capsules, Metadate CD extended-release capsules, Methylin
oral solution, Methylin
chewable tablets, Ritalin tablets, Ritalin SR sustained-release tablets, Ritalin LA extended-release capsules, and Strattera capsules.
Stimulant drugs--such as methyl-phenidate (Ritalin, Concerta, Metadate, and Methylin
)-remain the preferred method to date for treating ADHD, Dr.
Stimulant drugs--such as methylphenidate (Ritalin, Concerta, Metadate, Methylin
)--remain the preferred treatment for ADHD, Dr.
has expanded the Methylin
(methyl phenidate) chewable tablets recall to include all lots of the product because some tablets may contain too much or too little active ingredient.
$35,920,429.71 Teva USA Clarithromycin ER $35,895,162.63 Url Felodipine ER $35,706,081.95 Teva USA Ciprofloxacin HCl $35,656,036.02 Perrigo Co.
is recalling one lot of Methylin
CT (methylphenidate HCl) chewable tablets (5 mg) because the lot might contain up to three times the active ingredient.
It's not a first-line drug yet." Stimulant drugs--such as methylphenidate (Concerta, Metadate ER, Ritalin, and Methylin
; the latter two have both regular or extended release formulations)--are the preferred method to date for treating ADHD.
Beyond CNS and addiction therapy Mallinckrodt is developing several ADHD products, which will provide further therapeutic options for clinicians in addition to the supplier's current ADHD treatment mainstay, Methylin
methylphenidate HCI tablets USP.